CONTENTS:
- A mapping review of evaluations of alcohol policy restrictions targeting alcohol-related harm in night-time entertainment precincts. Taylor N., Miller P., Coomber K., Mayshak R., Zahnow R., Patafio B., et al., p. 1-13.
- Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study. Cunningham E.B., Amin J., Feld J.J., Bruneau J., Dalgard O., Powis J., et al., p. 14-23.
- Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits. Folch C., Lorente N., Majo X., Parés-Badell O., Roca X., Brugal T., et al., p. 24-29.
- Quantifying the societal cost of methamphetamine use to Australia. Tait R.J., Whetton S., Shanahan M., Cartwright K., Ferrante A., Gray D., et al., p. 30-36.
- A qualitative study of methamphetamine initiation among Chinese male users: Patterns and policy implications. Liu L., Chui W.H., Chai X., p. 37-42.
- Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Davis A., McCrimmon T., Dasgupta A., Gilbert L., Terlikbayeva A., Hunt T., et al., p. 43-50.
- Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities. Zlotorzynska M., Weidle P.J., Paz-Bailey G., Broz D., p. 51-58.
- Drug checking as a potential strategic overdose response in the fentanyl era. Laing M.K., Tupper K.W., Fairbairn N., p. 59-66.
- Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration. Wolfson-Stofko B., Elliott L., Bennett A.S., Curtis R., Gwadz M., p. 67-73.
- Direct-acting antiviral therapy for hepatitis C infection among people receiving opioid agonist treatment or heroin assisted treatment. Scherz N., Bruggmann P., Brunner N., p. 74-77.
- Generating sustainable collective action: Models of community control and governance of alcohol supply in Indigenous minority populations. Shanthosh J., Angell B., Wilson A., Latimer J., Hackett M.L., Eades A.-M., et al., p. 78-85.
- Action-focused, plain language communication for overdose prevention: A qualitative analysis of Rhode Island's overdose surveillance and information dashboard. Waye K.M., Yedinak J.L., Koziol J., Marshall B.D.L., p. 86-93.
- Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy. Grebely J., Conway B., Cunningham E.B., Fraser C., Moriggia A., Gane E., et al., p. 94-103.
- Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study. Bouscaillou J., Kikvidze T., Butsashvili M., Labartkava K., Inaridze I., Etienne A., et al., p. 104-111.